Nor Azman N. I. Iwana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nor Azman N. I. Iwana has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- El Hassane Anouar
Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia
2 shared publications - Hatem Ahmad Abuelizz
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
2 shared publications - Mohamed Marzouk
Chemistry of Tanning Materials and Leather Technology Department, Organic Chemicals Industries Division, National Research Centre, Dokki, Cairo 12622, Egypt
2 shared publications - Rashad Al-Salahi
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
2 shared publications - Rohaya Ahmad
Faculty of Applied Sciences, Universiti Teknologi MARA, 40450 Shah Alam, Selangor Darul Ehsan Malaysia
2 shared publications
Latest Publications
- Open Access
- 5 April 2019
- Published by Springer Nature in BMC Chemistry
- Vol. 13 (1) , 1-14
Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level. We have synthesized 25 tricyclic 2-phenoxypyrido[3,2-e][1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-ones hybrids and evaluated their α-glucosidase inhibitory activity. Compounds 6h and 6d have shown stronger activity than that of acarbose. Compound 6h exhibited the highest inhibition with an IC50 of 104.07 µM. Molecular modelling studies revealed that compound 6h inhibits α-glucosidase due to the formation of a stable ligand-α-glucosidase complex and extra hydrogen bond interactions, and directed in the binding site by Trp329.
- 5 April 2019
- Published by Springer Nature in BMC Chemistry
- Vol. 13 (1) , 1-14
Open AccessSynthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level. We have synthesized 25 tricyclic 2-phenoxypyrido[3,2-e][1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-ones hybrids and evaluated their α-glucosidase inhibitory activity. Compounds 6h and 6d have shown stronger activity than that of acarbose. Compound 6h exhibited the highest inhibition with an IC50 of 104.07 µM. Molecular modelling studies revealed that compound 6h inhibits α-glucosidase due to the formation of a stable ligand-α-glucosidase complex and extra hydrogen bond interactions, and directed in the binding site by Trp329.
- Open Access
Synthesis, Biological Activity and Molecular Docking of New Tricyclic Series as α-glucosidase Inhibitors
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level. We have synthesized 25 tricyclic 2-phenoxypyrido[3,2-e][1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-ones hybrids and evaluated their α-glucosidase inhibitory activity. Compounds 6h and 6d have shown stronger activity than that of acarbose. Compound 6h exhibited the highest inhibition with an IC 50 of 104.07 mM. Molecular modelling studies revealed that compound 6h inhibits α-glucosidase due to the formation of a stable ligand–α-glucosidase complex and extra hydrogen bond interactions, and directed in the binding site by Trp329.
Open AccessSynthesis, Biological Activity and Molecular Docking of New Tricyclic Series as α-glucosidase Inhibitors
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level. We have synthesized 25 tricyclic 2-phenoxypyrido[3,2-e][1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-ones hybrids and evaluated their α-glucosidase inhibitory activity. Compounds 6h and 6d have shown stronger activity than that of acarbose. Compound 6h exhibited the highest inhibition with an IC 50 of 104.07 mM. Molecular modelling studies revealed that compound 6h inhibits α-glucosidase due to the formation of a stable ligand–α-glucosidase complex and extra hydrogen bond interactions, and directed in the binding site by Trp329.